Home / Recalls / Cantrell Drug Company / D-1079-2017

D-1079-2017 Class II Terminated

Recalled by Cantrell Drug Company — Little Rock, AR

Recall Details

Product Type: Drugs
Report Date: August 16, 2017
Initiation Date: July 14, 2017
Termination Date: September 16, 2020
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 28779 syringes

Product Description

Rocuronium Bromide Injection Solution 5 mL, 50 mg/5 mL (10 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd. Little Rock, AR 72207 877-666-5222, NDC 52533-064-15

Reason for Recall

Lack of Sterility Assurance.

Distribution Pattern

Nationwide within the US

Code Information

Lot #: 9598, BUD: 8/2/2017; 9609, BUD: 8/5/2017; 9621, BUD: 8/7/2017; 9681, BUD: 8/19/2017; 9765, BUD: 9/5/2017; 10102, BUD: 10/24/2017; 10347, BUD: 11/26/2017; 10357, BUD: 11/26/2017; 10387, BUD: 12/3/2017; 10478, 10505, 10585, BUD: 12/16/2017

Other recalls by Cantrell Drug Company

D-1067-2017 Class II — Glycopyrrolate Injection Solution, 1 mL 0.2 mg/1 mL (0.2 mg/mL) Single-Dose Syri (July 14, 2017)
D-1062-2017 Class II — Ephedrine Sulfate in 0.9% Sodium Chloride 5 mL, 25 mg/5 mL (5 mg/mL) Single-Dose (July 14, 2017)
D-1073-2017 Class II — Diltiazem HCl 125 mg in 5% Dextrose 125 mL Single-Dose- Bag, Rx Only, Cantrell (July 14, 2017)
D-1061-2017 Class II — Ephedrine Sulfate in 0.9% Sodium Chloride 10 mL, 50 mg/10 mL (5 mg/mL) Single-Do (July 14, 2017)
D-1063-2017 Class II — Ephedrine Sulfate Injection Solution 1 mL, 50 mg/1 mL (50 mg/mL) Single-Dose Sy (July 14, 2017)
D-1064-2017 Class II — Ephedrine Sulfate in 0.9% Sodium Chloride 5 mL, 50 mg/5 mL (10 mg/mL) Single-Do (July 14, 2017)
D-1075-2017 Class II — Sodium Bicarbonate 8.4% Injection Solution 50 mL, 50 mEq (1mEq/mL) Single-Dose S (July 14, 2017)
D-1068-2017 Class II — Succinylcholine Chloride Injection Solution 10 mL, 200 mg/10 mL (20 mg/mL) Singl (July 14, 2017)
D-1071-2017 Class II — Norepinephrine Bitartrate 16 mg Added to 0.9% Sodium Chloride 250 mL (64 mcg per (July 14, 2017)
D-1076-2017 Class II — Adenosine in 0.9% Sodium Chloride 30mL, 90 mg/30 mL (3 mg/mL) Single-Dose Syring (July 14, 2017)